Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Omkar Speciality has received patent for beta ketoester chemical process

Omkar Speciality Chemicals has received a process patent for a chemical that is used in pharma industry.

The Chairman and Managing Director of the company, Pravin Herlekar has said that the patent, fourth one for the firm, is for beta ketoester chemical.

He added that there are seven more patents in the pipeline.

According to him, Omkar Speciality Chemicals will be manufacturing beta ketoester from the company’s existing facility.

Read EquityPandit’s Technical Analysis on Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile